JAGUAR HEALTH, INC. Inventory Write-down
JAGUAR HEALTH, INC. (JAGX) reported Inventory Write-down of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-04-07
- JAGUAR HEALTH, INC. inventory write-down for the quarter ending 2017-09-30 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for the quarter ending 2017-06-30 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for the quarter ending 2017-03-31 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for the quarter ending 2016-12-31 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for fiscal 2025 was $2.00M.
- JAGUAR HEALTH, INC. inventory write-down for fiscal 2016 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for fiscal 2015 was $0.00.
- JAGUAR HEALTH, INC. inventory write-down for fiscal 2014 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.00M 10-K · filed 2026-04-07 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 | $0.00 derived: sum of 4 quarters · filed 2017-11-20 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $0.00 derived: sum of 3 quarters · filed 2017-08-09 | $0.00 derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | $0.00 10-Q/A · filed 2017-06-23 | $0.00 derived: sum of 2 quarters · filed 2017-06-23 | $0.00 derived: sum of 3 quarters · filed 2017-06-23 | $0.00 derived: sum of 4 quarters · filed 2017-06-23 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $0.00 derived: sum of 2 quarters · filed 2017-02-15 | $0.00 derived: sum of 3 quarters · filed 2017-02-15 | $0.00 10-K · filed 2017-02-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-29 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |